Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol fMRI study in knee osteoarthritis with central sensitization
2016-005082-31Phase 4Active
- Sponsor
- Hospital del Mar
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of tapentadol in knee osteoarthritis (OA), sponsored by Hospital del Mar. Primary endpoint: Brain response to knee painful stimulation. Started Jan 2017; status: active.
02
Drugs
tapentadol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2016-005082-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005082-31.